Sanai Health Industry Group Company Limited (HKG:1889)
Hong Kong · Delayed Price · Currency is HKD 0.4400
+0.0150 (3.53%)
At close: Feb 13, 2026
HKG:1889 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 95.71 | 85.22 | 107.77 | 175.92 | 67.61 | 121.4 | |
Revenue Growth (YoY) | 0.24% | -20.92% | -38.74% | 160.21% | -44.31% | 48.32% |
Cost of Revenue | 78.86 | 68.35 | 78.6 | 84.41 | 27.16 | 90.71 |
Gross Profit | 16.86 | 16.86 | 29.17 | 91.51 | 40.45 | 30.7 |
Selling, General & Admin | 36.89 | 32.31 | 14.17 | 19.11 | 14.84 | 14.84 |
Operating Expenses | 35.91 | 31.51 | 10.74 | 32.16 | 15.72 | 14.84 |
Operating Income | -19.05 | -14.65 | 18.43 | 59.35 | 24.72 | 15.85 |
Interest Expense | -2.38 | -2.2 | -2.03 | -1.79 | - | - |
Interest & Investment Income | 0.57 | 0.57 | 0.45 | 0.08 | 0.71 | 0.58 |
Earnings From Equity Investments | -0.19 | -0.46 | - | - | - | - |
Currency Exchange Gain (Loss) | - | - | - | - | 0.05 | 0.04 |
Other Non Operating Income (Expenses) | 0.83 | 3.91 | -0.02 | 2.03 | 0.01 | 0.21 |
EBT Excluding Unusual Items | -20.23 | -12.82 | 16.83 | 59.67 | 25.5 | 16.68 |
Gain (Loss) on Sale of Assets | -16.56 | -0.12 | - | -2.48 | - | -0.02 |
Other Unusual Items | - | - | 2.55 | -1.41 | - | - |
Pretax Income | -36.79 | -12.94 | 19.38 | 55.77 | 25.5 | 16.65 |
Income Tax Expense | 0.15 | 0.97 | 8.44 | 20.57 | 8.63 | 5.16 |
Earnings From Continuing Operations | -36.94 | -13.91 | 10.94 | 35.2 | 16.88 | 11.49 |
Earnings From Discontinued Operations | 17.31 | 17.31 | 2.43 | - | - | - |
Net Income to Company | -19.63 | 3.4 | 13.37 | 35.2 | 16.88 | 11.49 |
Minority Interest in Earnings | 3.69 | 1.49 | 5.27 | -5.98 | -7.85 | -5.07 |
Net Income | -15.94 | 4.89 | 18.63 | 29.22 | 9.03 | 6.42 |
Net Income to Common | -15.94 | 4.89 | 18.63 | 29.22 | 9.03 | 6.42 |
Net Income Growth | - | -73.75% | -36.23% | 223.73% | 40.53% | -94.11% |
Shares Outstanding (Basic) | 153 | 145 | 128 | 123 | 123 | 123 |
Shares Outstanding (Diluted) | 153 | 145 | 152 | 144 | 123 | 123 |
Shares Change (YoY) | 2.99% | -4.19% | 5.08% | 17.66% | - | - |
EPS (Basic) | -0.10 | 0.03 | 0.15 | 0.24 | 0.07 | 0.05 |
EPS (Diluted) | -0.10 | 0.03 | 0.13 | 0.22 | 0.07 | 0.05 |
EPS Growth | - | -73.55% | -43.10% | 208.51% | 38.51% | -94.11% |
Free Cash Flow | -2.04 | 10.63 | 320.61 | -56.22 | -38.81 | -1.86 |
Free Cash Flow Per Share | -0.01 | 0.07 | 2.11 | -0.39 | -0.32 | -0.01 |
Gross Margin | 17.61% | 19.79% | 27.07% | 52.02% | 59.82% | 25.28% |
Operating Margin | -19.91% | -17.19% | 17.11% | 33.73% | 36.57% | 13.06% |
Profit Margin | -16.65% | 5.74% | 17.29% | 16.61% | 13.35% | 5.29% |
Free Cash Flow Margin | -2.13% | 12.47% | 297.50% | -31.95% | -57.40% | -1.53% |
EBITDA | -16.43 | -12.54 | 21.56 | 62.59 | 28.14 | 19.34 |
EBITDA Margin | -17.17% | -14.72% | 20.01% | 35.58% | 41.62% | 15.93% |
D&A For EBITDA | 2.62 | 2.1 | 3.13 | 3.24 | 3.41 | 3.49 |
EBIT | -19.05 | -14.65 | 18.43 | 59.35 | 24.72 | 15.85 |
EBIT Margin | -19.91% | -17.19% | 17.11% | 33.73% | 36.57% | 13.06% |
Effective Tax Rate | - | - | 43.55% | 36.89% | 33.82% | 30.99% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.